大洋生物股东汪贤高拟减持不超57万股

Core Viewpoint - The announcement indicates that Wang Xianggao, a shareholder holding more than 5% of the shares, plans to reduce his stake in Dayang Bio (003017.SZ) by selling up to 570,000 shares, which represents 0.68% of the company's total shares, within a specified period [1] Group 1 - The reduction plan will commence 15 trading days after the announcement, specifically from January 12, 2026, to April 11, 2026, excluding any periods during which share reductions are prohibited by the China Securities Regulatory Commission or the Shenzhen Stock Exchange [1]